<DOC>
	<DOCNO>NCT03089918</DOCNO>
	<brief_summary>The purpose study investigate total body biodistribution radiation dosimetry 11C-JNJ-63779586 Positron Emission Tomography ( PET ) healthy young adult male ( Part A ) ; estimate compare uptake , distribution , clearance 11C-JNJ-63779586 brain PET mild Alzheimer Disease ( AD ) participant ( males/females ) age- gender-matched control participant ( Part B ) , correct regional cerebral blood flow difference ; model tissue specific kinetics 11C-JNJ-63779586 human brain appropriate input function ( IF ) ( Part B ) .</brief_summary>
	<brief_title>A Study Investigate Regional Brain Kinetics Brain Drug Transporters Using P-glycoprotein Breast Cancer Resistance Protein Substrates Using Positron Emission Tomography Ligand 11C-JNJ-63779586 Human Brain</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Part A Healthy men 18 55 year age , inclusive Body mass index ( BMI ) 18 30 kilogram per meter square ( kg/m^2 ) Â² , inclusive , body weight less 50 kilogram ( kg ) Part B Men woman mild Alzheimer 's Disease ( AD ) , age gendermatched control participant , 55 85 year age , inclusive BMI 18 35 kg/m^2 , inclusive , body weight less 50 kg Mild AD participant amyloid positive minimental state examination ( MMSE ) great equal ( &gt; = ) 20 . The match control participant amyloid negative MMSE &gt; = 26 , respectively History current clinically significant medical illness include ( limited ) cardiac arrhythmia cardiac disease , hematologic disease , coagulation disorder ( include abnormal bleeding blood dyscrasia ) , lipid abnormality , significant pulmonary disease , include bronchospastic respiratory disease , diabetes mellitus , hepatic renal insufficiency ( estimate glomerular filtration rate [ eGFR ] within screen period le 60 milliLitre per minute per 1.73 meter square [ mL/min/1.73 m^2 ] , thyroid disease , neurologic psychiatric disease , infection , illness investigator considers exclude participant could interfere interpretation study result Clinically significant abnormal value hematology , clinical chemistry , urinalysis screen admission study center deem appropriate investigator Participant clinically relevant abnormal physical neurological examination , vital sign 12lead electrocardiogram ( ECG ) Participant history epilepsy fit unexplained blackout vasovagal collapse within 10 year screen Participant past plan exposure ionize radiation combination plan administration study Positron Emission Tomography ( PET ) ligand Computerized Tomography ( CT ) scan would result cumulative exposure exceed local recommend exposure limit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>